To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC21043 | GGTI 2417 Featured |
GGTI 2417 is the methyl ester prodrug of GGTI-2418, a highly potent, competitive, and selective inhibitor of GGTase I.
More description
|
|
| DC21042 | GGTI-2147 Featured |
GGTI-2147 is a non-thiol peptidomimetic that inhibits GGTase I and blocks geranyl-geranylation of Rap1A (IC50=0.5 uM).
More description
|
|
| DC26147 | DANUGLIPRON(PF-06882961) Featured |
PF-06882961 is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R).
More description
|
|
| DC28220 | Rezafungin Featured |
Rezafungin (Biafungin) is a next-generation, broad-spectrum, and long-lasting echinocandin. Rezafungin shows potent antifungal activity against Candida spp., Aspergillus spp., and Pneumocystis spp..
More description
|
|
| DC10496 | PF06260933 Featured |
PF 06260933 is a potent and selective MAP4K4 inhibitor (IC50 value 3.7 nM for MAP4K4 a.k.a. HGK or ZC1) with suitable PK properties in mouse to be used as a tool in an in vivo model of diabetes, vascular inflammation and atherosclerosis.
More description
|
|
| DC46395 | Z-FY-CHO Featured |
Z-FY-CHO (Z-Phe-Tyr-CHO) is a potent and specific cathepsin L (CTSL) inhibitor.
More description
|
|
| DC70478 | HDAC3 inhibitor PT3 Featured |
HDAC3 inhibitor PT3 is a novel potent, selective, BBB-permeable HDAC3 inhibitor.PT3 exhibited higher selectivity for HDAC3 over HDAC1, HDAC6, and HDAC8 compared to the reference compound CI994.PT3 upregulated H3K9 acetylation, CREB 1, BDNF, TRKB, Nr4a2, c-fos, PKA, GAP 43 and MMP9 expression in mouse neuronal (N2A) cells.PT3 significantly improved the discrimination index in C57/BL6 mice in the novel object recognition (NOR) model, significant increased in H3K9 acetylation in hippocampus.PT3 upregulated CREB 1, BDNF, TRKB, Nr4a2, c-fos, PKA, GAP 43, PSD 95 and MMP9 expression in mice treated with PT3.
More description
|
|
| DC50098 | TRPV4 agonist-1 Featured |
TRPV4 agonist-1 free base is a transient receptor potential vanilloid 4 (TRPV4) agonist with an EC50 of 60 nM in the hTRPV4 Ca2+ assay.
More description
|
|
| DC60206 | Phenithionate Featured |
|
|
| DC11365 | Oritavancin (phosphate) Featured |
Oritavancin is a semisynthetic glycopeptide antibiotic that inhibits the growth of Gram-positive bacteria.
More description
|
|
| DC74095 | Ninerafaxstat 3HCl Featured |
Ninerafaxstat 3HCl
(CV-8972) is a small molecule compound that promotes glucose oxidation, decreases fatty acid oxidation and improve overall mitochondrial respiration, inhibits the growth and proliferation of cancer cells.
More description
|
|
| DC72144 | TH-Z145 Featured |
TH-Z145, a lipophilic bisphosphonate, is a FPPS inhibitor (IC50: 210 nM).
More description
|
|
| DC65617 | TH-Z93 Featured |
TH-Z93, a lipophilic bisphosphonate, is a FPPS inhibitor (IC50: 90 nM).
More description
|
|
| DC11203 | ORIC-101 Featured |
ORIC-101 (ORIC101) is a highly potent, selective steroidal glucocorticoid receptor (GR) antagonist (IC50=5.6 nM) with reduced androgen receptor (AR) agonistic activity.
More description
|
|
| DC26173 | YM-53601 Featured |
YM-53601 is a squalene synthase inhibitor (IC50s = 79 and 90 nM in HepG2 cells and rat liver microsomes, respectively).
More description
|
|
| DC65271 | Pseudouridimycin(PUM) Featured |
Pseudouridimycin (PUM), an antibiotic, is a selective bacterial RNA polymerase (RNAP) inhibitor. Pseudouridimycin is a C-nucleoside analogue that is effective against both Gram-negative and Gram-positive bacteria.
More description
|
|
| DC65267 | CDK2-IN-3 (compound 3) Featured |
CDK2-IN-3 (compound 3) is a potent and selective CDK2 inhibitor with an 50 of 60 nM.
More description
|
|
| DC46182 | Didemnin B Featured |
Didemnin B is a depsipeptide extracted from the marine tunicate Trididemnin cyanophorum. Didemnin B can be used for the research of cancer.
More description
|
|
| DC65312 | Icenticaftor(QBW251) Featured |
Icenticaftor, also known as QBW251 is a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
More description
|
|
| DC22444 | Leptomycin B Featured |
A potent and specific nuclear export inhibitor that binds to and inhibits CRM1 (XPO1).
More description
|
|
| DC28133 | Prostaglandin D2 Featured |
Prostaglandin D2 (PGD2) is one of the major PGs actively produced in the brain of various mammals. Prostaglandin D2 is one of the most potent endogenous sleep promoting substances. PGD2 plays a protective role by suppressing inflammation.
More description
|
|
| DC21709 | SU 16f Featured |
SU 16f is a potent and selective PDGFRβ inhibitor with IC50 of 10 nM, displays >14-fold, >229-fold and >10,000-fold selectivity over VEGFR2, FGFR1 and EGFR respectively.
More description
|
|
| DC22457 | NAPQI Featured |
A toxic byproduct, iminoquinone metabolite of acetaminophen that covalently binds to the active site of MIF.
More description
|
|
| DC7778 | Lometrexol(LY 264618) Featured |
Lometrexol is a tight-binding antifolate inhibitor of the purine de novo enzyme glycinamide ribonucleotide formyltransferase (GARFT), was the first GARFT inhibitor to be investigated clinically.
More description
|
|
| DC26186 | PXS-5120A Featured |
PXS-5120A is a potent, irreversible inhibitor that is >300-fold selective for LOXL2 over LOX.
More description
|
|
| DC72367 | TDI-11861 Featured |
TDI-11861 is second-generation soluble Adenylyl Cyclase (sAC, ADCY10) inhibitor with slow dissociation rates. TDI-11861 inhibits sAC cellular with an IC50 value of 5.5 nM.
More description
|
|
| DC60104 | Episilvestrol Featured |
Episilvestrol, a derivative of silvestrol, is isolated from the fruits and twigs of Aglaia silvestris, Episilvestrol exhibited potent in vitro cytotoxic activity
More description
|
|
| DC47581 | BMS-986278 Featured |
BMS-986278 is a potent lysophosphatidic acid receptor 1 (LPA1) antagonist, with a human LPA1 Kb of 6.9 nM.
More description
|
|
| DC22691 | MK-4618 Featured |
A potent and selective full β3 adrenergic receptor agonist with EC50 of 1.1 nM.
More description
|
|
| DC46954 | CVN03650(IL-17 modulator 4) Featured |
IL-17 modulator 4 is a prodrug of IL-17 modulator 1. IL-17 modulator 1 is an orally active, highly efficacious IL-17 modulator.
More description
|
|